Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.5 (
5'-nucleotidase
)
3,167
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mutants in which the expression of periplasmic enzymes by whole cells is reduced (termed "cryptic") are also found to show greatly reduced uptake of labeled adenosine 5'-monophosphate (5'-AMP), providing a rapid assay for crypticity. The crypticity of 3'- and
5'-nucleotidase
has been examined as a function of substrate concentration. The Km for 3'- or 5'-AMP increases in the
cryptic
mutants when whole cells are used as the enzyme source. The Vmax is not altered. Electrophoretic analysis of protein prepared from cell envelopes showed that three
cryptic
mutants have a polypeptide absent from the outer membrane and a relatively high proportion of a polypeptide in the inner membrane. Analysis of the molar ratios of constituent sugars of the lipopolysaccharides showed no differences between three
cryptic
mutants and the parent strain. One
cryptic
mutant (3--41), however, has altered sensitivity to phage T4. By selection for phage resistance, derivatives of the
cryptic
mutants that are deoxycholate sensitive have been obtained. These mutants are no longer
cryptic
. We suggest that
cryptic
mutants have an altered outer membrane, with decreased permeability to 3'- and 5'-AMP, as a result of an altered polypeptide.
...
PMID:Mutants of Escherichia coli "cryptic" for certain periplasmic enzymes: evidence for an alteration of the outer membrane. 32 Jan 75
5'-Nucleotidase, purified to homogeneity from chicken gizzard using published procedures [Dieckhoff, J., Knebel, H., Heidemann, M. and Mannherz, H. G. (1985) Eur. J. Biochem. 151, 377-383] was incorporated into artificial phospholipid vesicles after prolonged dialysis against detergent-free buffer or by a gel filtration procedure. After dialysis the obtained liposomes exhibit a mean diameter of 80 nm and contain
5'-nucleotidase
at random orientation, demonstrated by finding up to 50% of the total liposome-incorporated
AMPase
activity to be
cryptic
, i.e. could only be measured after their permeabilization by addition of detergent. By affinity chromatography a phospholipid vesicle fraction could be obtained containing almost exclusively
cryptic
AMPase
activity, thus representing the inside-out orientation of
5'-nucleotidase
. Comparative analysis of physiochemical and enzymatic properties of
5'-nucleotidase
reveals differences between the detergent-solubilized and the liposome-incorporated
5'-nucleotidase
including a changed accessibility of the enzyme to polyclonal and monoclonal antibodies. Binding and
AMPase
inhibition studies with different polyclonal antibodies strongly indicate to the existence of a cytoplasmic domain of chicken gizzard
5'-nucleotidase
. F-actin appears preferentially to interact with the cytoplasmic domain of liposome-incorporated
5'-nucleotidase
.
...
PMID:Reconstitution of purified chicken gizzard 5'-nucleotidase in phospholipid vesicles. Evidence for its transmembraneous character and the existence of functional domains on both sides of the phospholipid bilayer. 302 13
Mutants of Escherichia coli have been selected for the absence of
5'-nucleotidase
(uridine diphosphate-sugar hydrolase) and 3'-nucleotidase (2',3'-cyclic phophodiesterase). Mutants selected for the absence of
5'-nucleotidase
are of two kinds: those that lack detectable activity for the enzyme (Ush(-)), and those that possess activity when cell extracts are assayed, but not when intact cells are assayed (
cryptic
; Crp(-)). The latter class is probably identical to a type of mutant previously reported by Ward and Glaser. When mutants are selected for the absence of 3'-nucleotidase, Crp(-)mutants are also obtained. Thus far, however, mutants totally lacking this enzyme have not been found. The location on the genetic map of one ush mutation is at position 11 min and that of one crp mutation at approximately 67 min. In the crp mutant,
5'-nucleotidase
and 3'-nucleotidase remain located in the periplasm. This mutant is also
cryptic
for alkaline phosphatase but not for acid hexose phosphatase. Treatment of cells with ethylenediamine-tetraacetate substantially alleviated crypticity. These data are discussed in terms of the organization of periplasmic enzymes and of the outer membrane as a permeability barrier.
...
PMID:Mutants of Escherichia coli K-12 "cryptic," or deficient in 5'-nucleotidase (uridine diphosphate-sugar hydrolase) and 3'-nucleotidase (cyclic phosphodiesterase) activity. 435 92
Activities of the ecto-enzymes
5'-nucleotidase
(5'-N) and phosphatase were determined on the surface of intact cells from 15 different established lines of human B- and T-lymphoblasts. Whereas all the lines express phosphatase, 10 of the lines were negative for 5'-N. 5'-N-negative cell lines are found among B as well as T cells, and they do not carry
cryptic
enzyme activity. In a 5'-N-positive line activity of this enzyme is correlated with growth showing a peak during the logarithmic phase. On the other hand, inhibition of 5'-N does not change the growth curve of this line. Neuraminidase treatment of the cell surface brings about an increase in phosphatase but not in 5'-N activity. 5'-N of two B-cell lines of human peripheral blood lymphocytes shows complete crossreactivity with an antiserum obtained against human placental 5'-N. However, the enzyme of one lymphoma line with B-cell properties (EHR-A-Ramos) does not cross-react with this serum. The results are discussed with respect to suitability of these lymphoblast lines as model systems for the study of immunodeficiencies.
...
PMID:Ectoenzymes on the surface of cells from human lymphoblastoid lines: 5'-nucleotidase and phosphatase. 625 29